A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study

• Main Authors: Cressey T., Siriprakaisil O., Klinbuayaem V., Quame-Amaglo J., Kubiak R., Sukrakanchana P., Than-in-at K., Baeten J., Sirirungsi W., Cressey R., Drain P.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85023612304&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40282
• Institution: Chiang Mai University

© 2017 The Author(s). Background: Tenofovir disoproxil fumarate (TDF) is key component of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) for HIV, but existing tools to monitor drug adherence are often inaccurate. Detection of tenofovir (TFV) in accessible biological samples, such a...